stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Supernus Pharmaceuticals IncSUPN
$30.4827.29%-11.44

Supernus Pharmaceuticals Inc (SUPN)

Date: 2026-11-03 16:00O: 28.35H: 31.20L: 28.35C: 30.48Vol: 948.6k

Supernus Pharmaceuticals Inc Stock (SUPN) Forecast

The Supernus Pharmaceuticals Inc (SUPN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $39.55, representing a +29.76% increase from the current price of $30.48. The highest analyst price target is $42.18, and the lowest is $36.92.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month SUPN Price Target
Average 40.63 (+33.29% Upside)

Is Supernus Pharmaceuticals Inc (SUPN) A Buy Now?

Oscillators
NameValueAction
RSI(14)21.89Buy
STOCH(9,6)55.75Neutral
STOCHRSI(14)100.00Sell
MACD(12,26)-1.24Sell
ADX(14)26.24Sell
William %R-87.19Buy
CCI(14)-363.58Sell
Buy: 2 · Sell: 4 · Neutral: 1Summary: Sell
Moving Averages
PeriodSimpleExponential
MA10
40.22
Sell
39.32
Sell
MA20
40.76
Sell
40.44
Sell
MA50
42.19
Sell
42.17
Sell
MA100
44.44
Sell
43.90
Sell
MA200
47.19
Sell
44.97
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, SUPN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 14 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on SUPN, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 21.89 indicates that SUPN is oversold. This indicates that SUPN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 55.75 indicates that SUPN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that SUPN is overbought. This suggests that SUPN price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 26.24 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of -363.58 indicates that SUPN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term SUPN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Supernus Pharmaceuticals Inc financial reports and earnings history, Supernus Pharmaceuticals Inc (SUPN) stock could reach $51.92 by 2030, $68.84 by 2040 and $94.42 by 2050. See the projected annual prices until 2050 of the Supernus Pharmaceuticals Inc stock below:

  • Supernus Pharmaceuticals Inc (SUPN) is expected to reach an average price of $60.25 in 2035, with a high prediction of $62.37 and a low estimate of $48.05. This indicates an +97.67% change from the last recorded price of $30.48.
  • Supernus Pharmaceuticals Inc (SUPN) stock is projected to chart a bullish course in 2040, with an average price target of $64.44, representing an +111.40% change from its current level. The forecast ranges from a conservative $54.64 to a sky-high $68.84.
  • Our analysts predict Supernus Pharmaceuticals Inc (SUPN) to change +132.47% by 2045, soaring from $70.06 to an average price of $70.86, potentially reaching $83.95. While $70.06 is the low estimate, the potential upside is significant.
  • Supernus Pharmaceuticals Inc (SUPN) stock is expected to climb by 2050, reaching an average of $92.38, a +203.08% change from its current level. However, a wide range of estimates exists, with high and low targets of $94.42 and $75.09, respectively, highlighting the market's uncertainty.

Supernus Pharmaceuticals Inc Stock (SUPN) Year by Year Forecast

Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2026

The predicted value for Supernus Pharmaceuticals Inc (SUPN) in 2026 is set at an average of $45.78. Estimates vary from a peak of $59.68 to a trough of $36.92, indicating an +50.21% surge from the present price of $30.48.

MonthAverageLowHighChange from today's price
December, 2026$40.60$36.92$42.18+33.20%

Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Supernus Pharmaceuticals Inc (SUPN) is $41.23, with a high forecast of $46.28 and a low forecast of $34.98. This indicates an +35.27% increase from the last price of $30.48.

MonthAverageLowHighChange from today's price
January, 2027$39.49$37.88$41.29+29.56%
February, 2027$40.07$37.78$42.08+31.46%
March, 2027$40.90$37.79$43.19+34.18%
April, 2027$42.15$39.87$43.05+38.28%
May, 2027$37.50$36.64$44.43+23.03%
June, 2027$37.93$34.98$38.54+24.44%
July, 2027$38.50$35.89$38.95+26.31%
August, 2027$40.60$37.84$40.82+33.19%
September, 2027$45.70$40.36$45.74+49.93%
October, 2027$44.88$43.04$46.28+47.24%
November, 2027$42.74$40.28$45.97+40.21%
December, 2027$44.32$42.01$45.59+45.40%

Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2028

In 2028, Supernus Pharmaceuticals Inc (SUPN) is projected to reach an average price of $45.27, with a high projection of $52.56 and a low estimate of $38.09. This indicates an +48.52% rise from the last price of $30.48.

MonthAverageLowHighChange from today's price
January, 2028$47.88$42.25$48.26+57.08%
February, 2028$46.08$45.17$48.80+51.17%
March, 2028$51.13$46.58$52.14+67.74%
April, 2028$49.79$47.83$52.56+63.34%
May, 2028$45.47$44.98$50.64+49.17%
June, 2028$46.64$44.88$48.38+53.00%
July, 2028$45.92$43.84$49.68+50.64%
August, 2028$45.43$43.23$46.62+49.06%
September, 2028$40.34$39.76$46.05+32.36%
October, 2028$42.93$40.08$43.16+40.86%
November, 2028$42.63$40.02$43.74+39.88%
December, 2028$39.00$38.09$43.57+27.97%

Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2029

The 2029 price forecast for Supernus Pharmaceuticals Inc Stock (SUPN) is $40.17 on average, with a high prediction of $46.57 and a low estimate of $32.87. This represents an +31.79% increase from the previous price of $30.48.

MonthAverageLowHighChange from today's price
January, 2029$34.44$32.87$40.64+13.00%
February, 2029$38.35$33.96$39.71+25.83%
March, 2029$37.87$37.47$39.38+24.26%
April, 2029$39.25$37.10$40.89+28.78%
May, 2029$38.72$37.49$41.02+27.04%
June, 2029$40.79$37.37$43.39+33.83%
July, 2029$45.25$40.89$46.57+48.47%
August, 2029$41.25$39.80$45.64+35.34%
September, 2029$40.32$39.22$44.08+32.29%
October, 2029$38.31$36.79$40.60+25.69%
November, 2029$41.56$36.84$42.31+36.36%
December, 2029$45.91$38.40$46.38+50.63%

Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2030

Supernus Pharmaceuticals Inc Stock (SUPN) is expected to reach an average price of $45.09 in 2030, with a high forecast of $51.92 and a low forecast of $40.90. This signifies an +47.94% surge from the last price of $30.48.

MonthAverageLowHighChange from today's price
January, 2030$42.51$40.90$46.79+39.47%
February, 2030$43.46$41.16$44.11+42.59%
March, 2030$45.55$42.81$47.04+49.44%
April, 2030$48.10$44.93$50.87+57.81%
May, 2030$48.75$45.94$49.17+59.94%
June, 2030$49.35$47.31$50.29+61.91%
July, 2030$44.71$44.19$51.92+46.68%
August, 2030$43.85$42.04$45.77+43.86%
September, 2030$42.51$41.51$46.00+39.47%
October, 2030$43.49$40.95$45.06+42.68%
November, 2030$44.98$43.15$45.54+47.57%
December, 2030$43.86$42.69$45.54+43.89%

Similar to SUPN

XERSXERS$10.392.16%ALVOALVO$4.623.13%ANIPANIP$71.641.37%PAHCPAHC$38.780.10%ETONETON$51.962.26%PCRXPCRX$36.400.00%